AGX Argan Inc

Argan Inc. delivers power plant and industrial construction services through its subsidiaries, primarily in the US and internationally. Sector: Industrials.

Argan Inc (AGX) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

From a capital efficiency perspective, ROIC is 25.23%, WACC is 7.35%, and the economic spread is 17.89%. On balance, the company generate meaningful returns above their cost of capital, a hallmark of competitively advantaged businesses. Supporting metrics show ROE at 39.80% and ROA at 12.71%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company with credible compounding capacity if current operating execution persists.

Multiple analysis puts the company at trailing P/E of 29.59, forward P/E of 28.35, PEG of 1.31. Trailing and forward multiples are nearly identical, indicating the market is pricing the company on a relatively static earnings assumption. Growth-adjusted, the company looks reasonably valued — the PEG ratio implies the market is not extrapolating the growth narrative aggressively. At 1.50, the aggregate current ratio indicates adequate but not exceptional balance sheet coverage. The combined valuation and liquidity profile points to a company where current prices embed meaningful growth expectations, and where delivery against those expectations will drive the return outcome.

On the margin front: gross margin sits at 20.79%, operating margin at 15.36%, and free cash flow margin at 45.93%. At this level, gross margins suggest a more competitive or capital-intensive operating environment across the the company. Operating margins sit in a healthy range — not exceptional, but indicating reasonable operational efficiency. At this FCF margin level, the company have considerable financial flexibility without reliance on external financing. The combined margin read is functional rather than exceptional, which can increase sensitivity to cost pressure or slower demand.

On the forward picture: TTM revenue growth of 61.51% reflecting robust top-line expansion across the company. Forecasted EPS growth of 4.4% over the next year is supportive of the current valuation, suggesting the market is not paying for earnings that won't arrive. Analyst price targets suggest street expectations point to meaningful upside if execution holds on a 12-month view. Revenue growth is grounded in reported results; price targets are forward projections that embed assumptions about multiple expansion, earnings delivery, and macro conditions. The key risk in both directions is whether the company can maintain their operating trajectory as macro and sector conditions evolve. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Across the metrics reviewed, the evidence is consistently constructive — quality, growth, and valuation are pulling in the same direction.

The analysis above draws from quantitative data only and does not constitute personalized financial advice. Investors should conduct independent research and consider professional guidance before acting on any information presented here.